Eisai
Ben Boward, PhD, currently serves as the External Innovation Manager at Eisai US, a position held since October 2023. Prior experience includes various roles at Danaher Corporation within Leica Biosystems from July 2019 to October 2023, where Ben progressed from Business Development Specialist to Business Development Manager, participating in a comprehensive rotational program focusing on commercial and technical functions. Ben also worked as a Technology Transfer Intern at The University of Georgia Innovations Gateway from May 2018 to January 2019, contributing to patent assessments and market strategies. Earlier academic roles included tutoring in biology and chemistry at James Madison University. Ben holds a PhD in Biochemistry and Molecular Biology from The University of Georgia and completed the Credential of Readiness program at Harvard Business School Online.
This person is not in any offices
Eisai
12 followers
Eisai Co., Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company's business segments include pharmaceutical segment and other segment. The pharmaceutical segment is engaged in the research, develop, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The other segment consists of pharmaceutical raw materials, logistics services and business services businesses.